Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Infiltrating cribriform carcinoma of the breast. A clinico-pathologic and immunohistochemical study of 5 cases.

Marzullo F, Zito FA, Marzullo A, Labriola A, Schittulli F, Gargano G, De Girolamo R, Colonna F.

Eur J Gynaecol Oncol. 1996;17(3):228-31.

PMID:
8780923
2.

Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity.

Venable JG, Schwartz AM, Silverberg SG.

Hum Pathol. 1990 Mar;21(3):333-8.

PMID:
2312110
3.

Low-grade adenosquamous carcinoma of the breast. A clinocopathologic study of 32 cases with ultrastructural analysis.

Van Hoeven KH, Drudis T, Cranor ML, Erlandson RA, Rosen PP.

Am J Surg Pathol. 1993 Mar;17(3):248-58.

PMID:
8434705
6.

Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.

López-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernadó L, Menendez JA.

Oncol Rep. 2008 Dec;20(6):1369-74.

PMID:
19020716
7.

Neuroendocrine carcinomas of the breast.

Rovera F, Masciocchi P, Coglitore A, La Rosa S, Dionigi G, Marelli M, Boni L, Dionigi R.

Int J Surg. 2008;6 Suppl 1:S113-5. doi: 10.1016/j.ijsu.2008.12.007.

8.

[Pure colloid carcinoma of the breast: anatomoclinical study of seven cases].

Chtourou I, Makni SK, Bahri I, Abbes K, Sellami A, Fakhfakh I, Gouiaa N, Ayadi L, Frikha M, Daoud J, Boudawara TS.

Cancer Radiother. 2009 Jan;13(1):37-41. doi: 10.1016/j.canrad.2008.06.004. French.

PMID:
18703371
9.
10.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
11.

Metaplastic breast carcinoma: pathology and clinical outcome.

Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, Bertone E, Grio R, Massobrio M.

Anticancer Res. 2003 Jan-Feb;23(1B):669-73.

PMID:
12680165
12.
13.

Do clinical and immunohistochemical findings of pure mucinous breast carcinoma differ from mixed mucinous breast carcinoma?

Erhan Y, Ciris M, Zekioglu O, Erhan Y, Kapkac M, Makay O, Ozdemir N.

Acta Chir Belg. 2009 Mar-Apr;109(2):204-8.

PMID:
19499682
14.

Breast carcinoma in women 35 years and younger: a pathological study.

Fernandopulle SM, Cher-Siangang P, Tan PH.

Pathology. 2006 Jun;38(3):219-22.

PMID:
16753742
15.
17.

Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.

Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A.

Cancer. 2003 Sep 1;98(5):1055-60.

18.

Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients.

Shin SJ, DeLellis RA, Ying L, Rosen PP.

Am J Surg Pathol. 2000 Sep;24(9):1231-8.

PMID:
10976697
19.

Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast.

Mastropasqua MG, Maiorano E, Pruneri G, Orvieto E, Mazzarol G, Vento AR, Viale G.

Mod Pathol. 2005 Oct;18(10):1277-82.

20.

Female breast cancer with 'clandestine' lymph node metastases.

van Bogaert LJ.

East Afr Med J. 1998 Nov;75(11):644-6.

PMID:
10065176
Items per page

Supplemental Content

Support Center